|
04/11/2024
|
13:29
|
Scottish Health Technology Group publications
|
RNS
|
|
21/10/2024
|
15:22
|
Director Declaration
|
RNS
|
|
15/08/2024
|
10:39
|
Director/PDMR Shareholding
|
RNS
|
|
12/08/2024
|
07:00
|
First UK commercial sales of the CYP2C19-ID Kit
|
RNS
|
|
06/08/2024
|
07:00
|
Directorate Change
|
RNS
|
|
31/07/2024
|
07:00
|
NICE recommends CYP2C19-ID Kit in final guidance
|
RNS
|
|
15/07/2024
|
07:00
|
Breakthrough Device Designation from the U.S. FDA
|
RNS
|
|
27/06/2024
|
09:28
|
Short extension to NICE publication date
|
RNS
|
|
25/06/2024
|
07:00
|
Holding(s) in Company
|
RNS
|
|
24/06/2024
|
11:13
|
Holding(s) in Company
|
RNS
|
|
24/06/2024
|
11:12
|
Holding(s) in Company
|
RNS
|
|
24/06/2024
|
11:11
|
Holding(s) in Company
|
RNS
|
|
17/06/2024
|
16:41
|
Holding(s) in Company
|
RNS
|
|
13/06/2024
|
15:22
|
Holding(s) in Company
|
RNS
|
|
11/06/2024
|
12:54
|
Holding(s) in Company
|
RNS
|
|
07/06/2024
|
11:00
|
Holding(s) in Company
|
RNS
|
|
05/06/2024
|
15:45
|
Holding(s) in Company
|
RNS
|
|
05/06/2024
|
11:39
|
Holding(s) in Company
|
RNS
|
|
31/05/2024
|
15:56
|
Block listing returns
|
RNS
|
|
31/05/2024
|
11:24
|
Result of General Meeting
|
RNS
|
|
30/05/2024
|
07:00
|
Result of Open Offer and REX Offer
|
RNS
|
|
24/05/2024
|
07:00
|
Initial orders of the Genedrive MT-RNR1 Products
|
RNS
|
|
21/05/2024
|
11:00
|
Key CYP2C19-ID test performance milestone achieved
|
RNS
|
|
15/05/2024
|
07:00
|
Amendment to Open Offer timetable
|
RNS
|
|
14/05/2024
|
07:00
|
Publication of Circular and Notice of GM
|
RNS
|
|
10/05/2024
|
07:00
|
Completion of placing
|
RNS
|
|
09/05/2024
|
16:49
|
Proposed REX Retail Offer
|
RNS
|
|
09/05/2024
|
16:48
|
Proposed Fundraise for a minimum of £6.0 million
|
RNS
|
|
24/04/2024
|
15:36
|
Clinical Trial Agreement
|
RNS
|
|
03/04/2024
|
17:00
|
Application for Listing & Total Voting Rights
|
RNS
|
|
03/04/2024
|
07:00
|
NICE recommends the Genedrive CYP2C19-ID Kit
|
RNS
|
|
28/03/2024
|
07:00
|
Half-year Report
|
RNS
|
|
19/03/2024
|
15:53
|
Application for Listing & Total Voting Rights
|
RNS
|
|
15/03/2024
|
12:30
|
Receipt of R&D tax credit
|
RNS
|
|
19/02/2024
|
07:00
|
NICE Early Value Assessment update
|
RNS
|
|
06/02/2024
|
14:03
|
Director/PDMR Shareholding
|
RNS
|
|
02/02/2024
|
15:35
|
Total Voting Rights
|
RNS
|
|
19/01/2024
|
16:14
|
Total Voting Rights
|
RNS
|
|
15/01/2024
|
15:21
|
Total Voting Rights
|
RNS
|
|
10/01/2024
|
07:00
|
Total Voting Rights
|
RNS
|
|
02/01/2024
|
07:00
|
Equity Prepayment Facility drawdown
|
RNS
|
|
29/12/2023
|
11:44
|
Result of AGM
|
RNS
|
|
20/12/2023
|
16:57
|
Total Voting Rights
|
RNS
|
|
20/12/2023
|
07:00
|
Initial overseas orders of MT-RNR1 ID kit
|
RNS
|
|
07/12/2023
|
07:00
|
Total Voting Rights
|
RNS
|
|
06/12/2023
|
07:00
|
Total Voting Rights
|
RNS
|
|
06/12/2023
|
07:00
|
Posting of annual report and notice of AGM
|
RNS
|
|
04/12/2023
|
13:13
|
MT-RNR1 ID kit adopted for routine use in Brighton
|
RNS
|
|
30/11/2023
|
17:29
|
Block listing Interim Review
|
RNS
|
|
30/11/2023
|
07:00
|
Final Results
|
RNS
|